Recommended

Discover how to overcome low affinity or poor TCR yields that are slowing you down in this upcoming webinar – register your details today
WEBINAR | Discover how advances can expand the possibilities for drug discovery, from target validation to preclinical development
Facing roadblocks in obesity drug discovery? Discover how integrated, validated strategies are helping teams accelerate development and reduce risk – register your details now
Unlock the science, strategy and real-world impact behind the next generation of precision therapies – access our new brand report now >>
Safety data is no longer just a regulatory checkbox – it’s a strategic advantage. Find out more in our upcoming webinar, register your details today
WEBINAR | Join top cancer researchers to explore advances transforming early discovery, from new targets and models to the therapies of tomorrow
editorial-board

Dr Remco Jan Geukes Foppen

Meet our new advisor, Dr Remco Jan Geukes Foppen, an AI and life sciences expert driving global innovation in pharma with expertise in data, bioinformatics and clinical trial AI.

Remco_Foppen.

Remco Jan Geukes Foppen, PhD, is an AI and life sciences expert specialising in the pharmaceutical sector, and founder of Explainambiguity. With a global perspective, he integrates and implements AI-driven strategies that impact business decisions, always considering the human element.

His leadership has driven international commercial success in areas including image analysis, data management, bioinformatics, advanced clinical trial data analysis leveraging machine learning and federated learning. Remco Jan Geukes Foppen’s academic background includes a PhD in biology and a master’s degree in chemistry, both from the University of Amsterdam.

Connect on LinkedIn >>